AstraZeneca said its Enhertu cancer drug prolonged survival and slowed the progression of a type of breast cancer, opening the door to a much larger potential patient group https://t.co/ni5bxIvchC pic.twitter.com/WsdjeawJEO— Reuters (@Reuters) February 21, 2022
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


